Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-14-007272
Filing Date
2014-10-15
Accepted
2014-10-15 12:53:08
Documents
9
Period of Report
2014-08-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0814_il2minternational.htm 10-Q 682884
2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER f10q0814ex31i_il2mintl.htm EX-31.1 12235
3 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER f10q0814ex32i_il2mintl.htm EX-32.1 5209
  Complete submission text file 0001213900-14-007272.txt   4914894

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE dynh-20140831.xml EX-101.INS 667504
5 XBRL SCHEMA FILE dynh-20140831.xsd EX-101.SCH 37544
6 XBRL CALCULATION FILE dynh-20140831_cal.xml EX-101.CAL 33598
7 XBRL DEFINITION FILE dynh-20140831_def.xml EX-101.DEF 126741
8 XBRL LABEL FILE dynh-20140831_lab.xml EX-101.LAB 319804
9 XBRL PRESENTATION FILE dynh-20140831_pre.xml EX-101.PRE 246975
Mailing Address 3500 WEST OLIVE AVENUE SUITE 810 BURBANK CA 91505
Business Address 3500 WEST OLIVE AVENUE SUITE 810 BURBANK CA 91505 818-953-7585
il2m INTERNATIONAL CORP. (Filer) CIK: 0001520512 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 0131
Type: 10-Q | Act: 34 | File No.: 333-176587 | Film No.: 141157112
SIC: 2834 Pharmaceutical Preparations